Literature DB >> 24048222

Association between in-vitro fertilization, birth and melanoma.

Louise M Stewart1, C D'Arcy J Holman, Judith C Finn, David B Preen, Roger Hart.   

Abstract

A link between reproductive hormones and melanoma has long been suspected, and has been examined for numerous hormonal exposures, but the association between in-vitro fertilization (IVF) and melanoma has not been studied in depth. We used whole-population linked hospital and registry data to carry out a cohort study of women aged 20-44 years seeking hospital investigation and treatment for infertility in Western Australia from 1982 to 2002 with follow-up to 2010. The cohort comprised a total of 21 604 women followed for an average of 17.2 years. Of these, 7524 had IVF treatment, 14 870 gave birth and 149 women were diagnosed with an incident invasive melanoma. Using Cox regression analysis, we estimated hazard ratios (HRs) for melanoma associated with IVF and parity. Women who had IVF and gave birth had an increased rate of invasive melanoma compared with women who had IVF and remained nulliparous (HR 3.61; 95% confidence interval 1.79-7.26). There was little or no increase in the rate of invasive melanoma associated with giving birth in women who had non-IVF infertility treatment (HR 1.39; 95% confidence interval 0.88-2.20). These results suggest an association between reproductive factors and melanoma in the subgroup of women undergoing IVF treatment.

Entities:  

Mesh:

Year:  2013        PMID: 24048222     DOI: 10.1097/CMR.0000000000000019

Source DB:  PubMed          Journal:  Melanoma Res        ISSN: 0960-8931            Impact factor:   3.599


  8 in total

1.  Age at first birth and melanoma risk: a meta-analysis.

Authors:  Zhengyong Li; Mingjin Gu; Ying Cen
Journal:  Int J Clin Exp Med       Date:  2014-12-15

Review 2.  Use of fertility medications and cancer risk: a review and update.

Authors:  Lindsay Kroener; Daniel Dumesic; Zain Al-Safi
Journal:  Curr Opin Obstet Gynecol       Date:  2017-08       Impact factor: 1.927

3.  Cancer Risk in Women Treated with Fertility Drugs According to Parity Status-A Registry-based Cohort Study.

Authors:  Marte Myhre Reigstad; Ritsa Storeng; Tor Åge Myklebust; Nan Birgitte Oldereid; Anne Katerine Omland; Trude Eid Robsahm; Louise Annette Brinton; Siri Vangen; Kari Furu; Inger Kristin Larsen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-01-20       Impact factor: 4.254

Review 4.  Correlation between fertility drugs use and malignant melanoma incidence: the state of the art.

Authors:  Federica Tomao; Anselmo Papa; Giuseppe Lo Russo; Sara Zuber; Gian Paolo Spinelli; Luigi Rossi; Davide Caruso; Natalie Prinzi; Valeria Stati; Pierluigi Benedetti Panici; Silverio Tomao
Journal:  Tumour Biol       Date:  2014-06-27

5.  Effects of fertility drugs on cancers other than breast and gynecologic malignancies.

Authors:  Louise A Brinton; Kamran S Moghissi; Bert Scoccia; Emmet J Lamb; Britton Trabert; Shelley Niwa; David Ruggieri; Carolyn L Westhoff
Journal:  Fertil Steril       Date:  2015-07-29       Impact factor: 7.329

6.  Cancer risk among parous women following assisted reproductive technology.

Authors:  M M Reigstad; I K Larsen; T Å Myklebust; T E Robsahm; N B Oldereid; A K Omland; S Vangen; L A Brinton; R Storeng
Journal:  Hum Reprod       Date:  2015-06-24       Impact factor: 6.918

7.  Hospital mental health admissions in women after unsuccessful infertility treatment and in vitro fertilization: an Australian population-based cohort study.

Authors:  Louise M Stewart; C D'Arcy J Holman; James B Semmens; David Preen; Qun Mai; Roger Hart
Journal:  PLoS One       Date:  2015-03-25       Impact factor: 3.240

8.  Melanoma Following In Vitro Fertilization: Co-incident or Coincidence?

Authors:  Philip R Cohen; Christof P Erickson; Brooke R Sateesh; Nathan S Uebelhoer; Antoanella Calame
Journal:  Cureus       Date:  2019-06-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.